Rock Springs Capital Management LP Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001595725
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2025 · 91 positions · Total reported value $1.69B · Top-10 concentration 38.3% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 39.8% · 9 new · 28 cut · 8 exited
Active Share (vs S&P 500): 96.8% · vs QQQ: 99.2% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -7.5% · vs SPY -9.6% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -2.4% · vs SPY -4.5% · Latest Value $1.85B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2025 13F filing, Rock Springs Capital Management LP disclosed 91 equity positions with a combined reported value of $1.69B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 38.3% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2025 were ARGX ($105.29M), LLY ($80.42M), RYTM ($72.42M). By sector, the heaviest allocations are Health Care 83.2%, Consumer Discretionary 2.5%. Versus the prior quarter, allocation shifted toward Health Care (+2.0pp) and away from Consumer Discretionary (-0.9pp), Other (-1.0pp).
Versus the prior quarter, Rock Springs Capital Management LP opened 9 new positions, trimmed 28 and fully exited 8, a turnover rate of 39.8% of positions. The portfolio's overlap with the prior quarter was 83% of names.
The largest new positions opened in Q3 2025 were HTFL ($8.41M), MBX ($4.95M), BBIO ($4.41M).
Of the 8 positions fully exited versus the prior quarter, the largest were BPMC ($23.78M), UNH ($15.75M), OSCR ($15.01M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2025)
Fully Exited (vs previous quarter)
- BPMC BLUEPRINT MEDICINES CORP · prev qtr: $23.78M
- UNH UNITEDHEALTH GROUP INC · prev qtr: $15.75M · history
- OSCR OSCAR HEALTH INC · prev qtr: $15.01M
- NUVL NUVALENT INC · prev qtr: $7.12M
- CGEM CULLINAN THERAPEUTICS INC · prev qtr: $5.03M
- LUNG PULMONX CORP · prev qtr: $1.69M
- SRPT SAREPTA THERAPEUTICS INC · prev qtr: $1.17M
- ADAPY ADAPTIMMUNE THERAPEUTICS PLC · prev qtr: $595.29K
Insider Transactions (Form 4)
Latest Rock Springs Capital Management LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Rock Springs Capital Management LP is an SEC-registered 13F filer based in Baltimore, MD, United States. As of Q2 2026 it reported 104 US equity positions with a combined value of $2.05B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: BALTIMORE, MD, United States
- SEC registration: 801-78511 (status: Approved), registered 2013-09-27
- Regulatory AUM (Form ADV): $2.43B as of 2026-03-24
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 2 private funds, of which 2 hedge funds
Portfolio Structure
- 104 positions · $2.05B reported value (Q2 2026)
- Top 10 holdings = 44.0% of reported value
- Largest position: RVMD (REVOLUTION MEDICINES INC) at 10.1%
- Average position size: $19.70M
Sector Tilt
- Health Care 96.8%
- Industrials 1.1%
- Consumer Discretionary 1.0%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 16 new, 35 added, 31 reduced, 12 exited
- 22 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
142.75K | $105.29M | 6.25% | Reduce | |
| 2 |
|
105.40K | $80.42M | 4.77% | Reduce | |
| 3 |
|
717.10K | $72.42M | 4.29% | Reduce | |
| 4 |
|
137.75K | $63.18M | 3.75% | Reduce | |
| 5 |
|
1.34M | $62.36M | 3.70% | Hold | |
| 6 |
|
597.05K | $56.21M | 3.33% | Reduce | |
| 7 |
|
761.13K | $55.80M | 3.31% | Reduce | |
| 8 |
|
385.00K | $55.44M | 3.29% | Reduce | |
| 9 |
|
2.16M | $51.74M | 3.07% | Add | |
| 10 |
|
214.50K | $42.64M | 2.53% | Reduce | |
| 11 |
|
235.00K | $40.42M | 2.40% | Reduce | |
| 12 |
|
958.54K | $38.48M | 2.28% | Reduce | |
| 13 |
|
1.25M | $37.49M | 2.22% | Reduce | |
| 14 |
|
82.00K | $36.67M | 2.17% | Hold | |
| 15 |
|
360.25K | $35.17M | 2.09% | Add | |
| 16 |
|
851.74K | $34.20M | 2.03% | Reduce | |
| 17 |
|
74.25K | $33.86M | 2.01% | Reduce | |
| 18 |
|
593.50K | $32.47M | 1.93% | Add | |
| 19 |
|
120.50K | $30.53M | 1.81% | Reduce | |
| 20 |
|
626.53K | $29.75M | 1.76% | Reduce | |
| 21 |
|
794.13K | $29.57M | 1.75% | Hold | |
| 22 |
|
791.19K | $26.81M | 1.59% | Reduce | |
| 23 |
|
951.15K | $26.63M | 1.58% | Reduce | |
| 24 |
|
450.37K | $25.49M | 1.51% | Hold | |
| 25 |
|
125.00K | $25.38M | 1.50% | Reduce | |
| 26 |
|
2.95M | $24.96M | 1.48% | Add | |
| 27 |
|
793.65K | $24.01M | 1.42% | Hold | |
| 28 |
|
249.40K | $23.88M | 1.42% | Add | |
| 29 |
|
316.90K | $21.32M | 1.26% | Add | |
| 30 |
|
919.95K | $20.34M | 1.21% | Hold | |
| 31 |
|
721.54K | $18.67M | 1.11% | Reduce | |
| 32 |
|
617.40K | $17.94M | 1.06% | Hold | |
| 33 |
|
749.12K | $17.62M | 1.04% | Reduce | |
| 34 |
|
288.34K | $17.14M | 1.02% | Reduce | |
| 35 |
|
4.47M | $15.66M | 0.93% | Reduce | |
| 36 |
|
623.40K | $15.55M | 0.92% | Hold | |
| 37 |
|
540.40K | $15.52M | 0.92% | Add | |
| 38 |
|
408.31K | $15.48M | 0.92% | Add | |
| 39 |
|
1.95M | $15.35M | 0.91% | Reduce | |
| 40 |
|
151.75K | $15.21M | 0.90% | Hold | |
| 41 |
|
178.98K | $14.69M | 0.87% | Reduce | |
| 42 |
|
710.00K | $14.67M | 0.87% | Hold | |
| 43 |
|
1.01M | $14.48M | 0.86% | Add | |
| 44 |
|
686.11K | $14.04M | 0.83% | Reduce | |
| 45 |
|
580.68K | $12.89M | 0.77% | Reduce | |
| 46 |
|
89.75K | $12.60M | 0.75% | Add | |
| 47 |
|
2.29M | $12.60M | 0.75% | Hold | |
| 48 |
|
61.50K | $12.19M | 0.72% | Add | |
| 49 |
|
236.23K | $11.00M | 0.65% | Add | |
| 50 |
|
154.53K | $10.45M | 0.62% | Hold | |
FAQ
What did Rock Springs Capital Management LP buy in 2025-Q3?
In its 2025-Q3 13F filing, Rock Springs Capital Management LP reported 91 equity positions worth $1.69B in aggregate; its largest disclosed positions were ARGX ($105.29M), LLY ($80.42M), RYTM ($72.42M).
How large is Rock Springs Capital Management LP's portfolio?
Rock Springs Capital Management LP reported $1.69B of long equity holdings across 91 positions as of 2025-Q3. Top-10 holdings account for 38.3% of reported value.
What is Rock Springs Capital Management LP's investment style?
HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.